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Background: Genetic variants in inflammation-related genes have been associated with biliary stones and biliary
tract cancers in previous studies.
Methods: To follow-up on these findings, we examined 35 single nucleotide polymorphism (SNPs) in 5 genes
related to inflammation (IL8, NFKBIL, RNASEL, TNF, and VEGFA) in 456 participants with incident biliary tract cancer
cases (262 gallbladder, 141 extrahepatic bile duct, 53 ampulla of Vater), 982 participants with biliary stones, and 860
healthy controls in a population–based case–control study in Shanghai, China.
Results: Suggestive associations were observed for SNPs in VEGFA with biliary stones, IL8 with gallbladder and
ampulla of Vater cancers, and RNASEL with ampulla of Vater cancer (false discovery rate≤0.2).
Conclusion: These findings provide additional support for the role of inflammation in biliary stones and biliary tract
cancer risk and need further validation.
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Biliary tract cancers, which include cancers of the gall-
bladder, extrahepatic bile duct, and ampulla of Vater,
are rare, yet highly fatal malignancies [1]. Elevated in-
cidence rates have been reported in Native Americans
and Hispanic immigrants in the United States, certain
populations in Asia (including China, Korea, Japan and
India), and in some parts of Eastern Europe and South
America [2]. Previous clinical and population-based
studies have linked various inflammatory factors and
mechanisms with the development of biliary tract can-
cers [3-6]. For example, gallstones, the predominant
risk factor for biliary tract cancers, are thought to
cause repeated irritation of the biliary tact mucosa,* Correspondence: felipe.castro@nih.gov
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reproduction in any medium, provided the orleading to chronic inflammation and eventual malig-
nant changes [2].
Variants in genes involved in inflammatory pathways
have been linked to biliary tract cancer and biliary stones.
For example, studies in India, a high-risk population for
gallbladder cancer, have shown that polymorphisms in
IL1 [7], TNF-alpha [8], and CCR5 [9] are associated with
gallbladder cancer. Data from our population-based
study of biliary tract cancers in Shanghai suggested that
variants in PTGS2 [10], IL8, IL8RB, RNASEL, NOS2 and
VEGF were associated with biliary tract cancer and/or
stones [11]. To follow-up on these initial findings, in this
analysis we examined an additional 28 SNPs in four of
the candidate genes we previously identified (IL8, RNA-
SEL, TNF, and VEGFA) in our population-based study in
Shanghai. We also evaluated five SNPs in NFKBIL, a
novel gene in the major histocompatibility complex
(MHC) class I region that was not evaluated previously.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Study participants
The study protocol was approved by the Institutional Re-
view Boards of the USA National Cancer Institute and
Shanghai Cancer Institute. All participants provided writ-
ten informed consent. The methods of the Shanghai Bil-
iary Tract Cancer Study have been reported [11]. Briefly,
cases were residents of urban Shanghai between the ages
of 40 and 74. They were diagnosed with biliary tract can-
cer (ICD-9 156) between 1997 and 2000, and identified
at 42 collaborating hospitals. Biliary stone cases without
a history of cancer were ascertained from the same hos-
pitals and matched to index cancer cases on hospital,
gender, and age (within 5 years). Biliary tract cancer and
biliary stone cases were confirmed by an expert panel re-
view of clinical and pathology records. Population con-
trols were healthy subjects without a history of cancer
selected from the Shanghai Resident Registry and
frequency-matched to cancer cases in a 1-to-1 ratio by
gender and age (5-yr intervals). Biliary stone status
among population controls was assessed by abdominal
ultrasound or self-reported history. Cases were inter-
viewed within three weeks of diagnosis. The interview re-
sponse rate was over 95% for cases and 82% for controls.Gene and SNP selection and genotyping
The variants included in this analysis were chosen
based on a priori evidence for a role in the immune/Table 1 Selected inflammatory genes and their association w
Gene symbol (name) Gene function Chromosom
location
IL8 (interleukin 8) Neutrophil chemotaxis 4q12-q13
NFKBIL (nuclear factor of kappa
light polypeptide gene enhancer
in B-cells inhibitor-like 1)
Encodes divergent member
of I-kappa-B family proteins
6p21.3














cell growth, cell migration,
apoptosis
6p12
1Previously reported variants associated with the risk of biliary stones and/or biliaryinflammatory response [12,13] or biliary disease [11].
We selected 35 SNPs in 5 genes, including 30 SNPs in
the candidate genes identified in our previous study
(IL8, RNASEL, TNF and VEGFA), as well as 5 SNPs in
the NFKBIL gene that was not evaluated previously
(Table 1). Genomic DNA was extracted from buffy coat
using phenol-chloroform extraction. All genotyping was
performed by TaqMan (Applied Biosystems, Foster
City, CA) at the National Cancer Institute Core Genotyp-
ing Facility (CGF, Advanced Technology Corporation,
Gaithersburg, MD) (http://cgf.nci.nih.gov/home.cfm).
Eight samples were randomly selected as quality control
(QC) samples; six replicates from each sample were
interspersed among genotyping assays and blinded to
laboratory personnel. There was 100% concordance
among the QC specimens, and the genotyping comple-
tion rate for the SNPs was 98%.Statistical analysis
The final analysis included subjects who completed the
interview and for whom we had DNA samples and
genotyping results. A total of 456 biliary tract cancer
cases (262 gallbladder, 141 extrahepatic bile duct and 53
ampulla of Vater), 982 biliary stone cases (252 bile duct,
730 gallstone), and 860 controls, were included. Hardy-
Weinberg equilibrium of allele frequencies for all SNPs
was tested among controls using the chi-square test. Un-
conditional logistic regression was conducted to estimateith biliary stones and cancer in the Shanghai population
Evaluated SNPs













































tract caner in the Shanghai population study.
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the associations between SNPs (using additive and co-
dominant genetic models) and biliary stone and cancer
risks. Biliary stone cases were compared with healthy
controls without stones; gallbladder cancer cases were
compared with population controls without a history of
cholecystectomy; and bile duct and ampulla of Vater
cancer cases were compared with all population con-
trols. Statistical interactions between SNPs and biliary
stones were examined using the likelihood ratio test in a
logistic regression model. Risk estimates were adjusted
for age (categorical) and sex, and further evaluated for
other potential confounding factors. To account for
multiple comparisons, we used the Benjamini-Hochberg
method to control for the false discovery rate (FDR)
[14], considering a FDR≤0.2 being noteworthy, as per
previous studies [15,16]. We also calculated a gene-
based summary p-value using the minP test [17] for each
of the five genes using the SNPs examined in this ana-
lysis and the SNPs from our previous study [11].
Results
The distribution of selected characteristics among cases
and controls used in the current analysis (Additional file 1:
Table S1) is similar to the distributions reported previously
(11). Of the 35 SNPs examined, statistically significant
(p<0.05) associations were seen for VEGFA rs9367173 and
rs6905288 with biliary stones, IL8 rs10805066 with gall-
bladder and ampulla of Vater cancers, and RNASEL
rs672527 with ampulla of Vater cancer (Table 2). Individ-
ual SNP-associations are shown in Additional file 2:
Table S2. Adjustment for biliary stones did not change
the effect of these SNPs on cancer, except for IL8
rs10805066 and gallbladder cancer, which was no longer
statistically significant (data not shown). Stratifying by bil-
iary stone status did not identify additional associations.
The associations noted above were robust to multiple
comparisons at the FDR p≤0.2 level, with FDR p-values
ranging between 0.09 and 0.2. Including SNPs from this
analysis and our previous study [11] in the minP test did
not result in additional significant gene-based associations
(Additional file 3: Table S3).
Discussion
Following-up on findings suggesting an association be-
tween inflammation-related genes and biliary stones
and cancer [11], in this analysis we expanded the gene
coverage of four previously identified genes and exam-
ined another gene not previously studied in the Shanghai
Biliary Tract Cancer Study. We observed suggestive asso-
ciations for SNPs in VEGFA with biliary stones, RNASEL
with ampulla of Vater cancer, and IL8 with gallbladder
and ampulla of Vater cancers after correcting for multiple
comparisons (FDR≤0.2).Genetic susceptibility to biliary stones was linked to
two SNPs in VEGFA. These two SNPs, rs9367173 and
rs6905288, are located downstream of VEGFA and are
neither in linkage disequilibrium (LD) with each other,
nor in LD with the other VEGFA SNPs we examined.
VEGFA is a signal protein that is fundamental in vascu-
lar permeability and angiogenesis [18]. Thus, the role of
VEGFA in gallstones susceptibility could be attributed to
the process of blood vascularization during acute and/or
chronic inflammation; however, the functional effects of
these variants are unknown. To our knowledge, this
study is the first to report an association between
VEGFA and biliary stones. In our previous study,VEGFA
was not associated with biliary stones, but rather VEGFA
rs3025039 was associated with gallbladder cancer. This
variant is not in LD with the two VEGFA SNPs we iden-
tified in this analysis.
We also found an increased risk of ampulla of Vater
cancer with RNASEL rs672527, which is located in an in-
tronic region of the gene. RNASEL is a key component
of the innate immune system and participates in the
process of apoptosis [19], but the functional effect of
rs672527 is unknown. Other polymorphisms in the RNA-
SEL gene have been associated with an increased risk of
such cancers as prostate, head and neck, uterine cervix
and breast [20,21]; however, this is the first report to our
knowledge of an association of rs672527 with cancer. We
have previously shown that another RNASEL SNP
(rs486907) was associated with biliary stones. These two
SNPs are not in LD.
IL8 rs10805066, which was linked with increased risks
of ampulla of Vater and gallbladder cancers, is located
outside the promoter region of the gene. No functional
effects of the variant have been reported. IL8 chemokine
has been recognized as a potent mitogenic/angiogenic
and inflammatory factor [22], which could support its
participation in biliary tract cancer development. In our
previous study, other variants in IL8 (rs4073, rs2227307
and rs27306, all in LD) were associated with bile duct
stones [11]. These three SNPs are not in LD with
rs10805066.
The associations between RNASEL and IL8 variants
with biliary tract cancers were independent of biliary
stones. In our previous study, some, but not all genetic
variants interacted significantly with biliary stone status
to effect biliary cancer risk (Hsing, 2008). It has been
suggested that most of the inflammatory processes of
biliary tract cancer are linked to biliary stones; however,
not all biliary cancer cases have prior stones, and other
inflammatory conditions such as cholecystitis, history of
gastric or duodenal ulcers have been reported to play a
role [23]. The cascade of inflammatory events in relation
to the genes detected in this or previous studies, with or
without the presence of biliary stones is unclear. In
Table 2 Odds Ratios (ORs) and 95% Confidence Intervals (CIs) for the association between inflammatory variants and









VEGFA 9921bp 3' of STP A>G rs9367173
GG 539 (82.9) 837 (86.8) 1.0
AG 102 (15.7) 126 (13.1) 0.8 (0.60-1.07)
AA 9 (1.4) 6 (0.6) 0.4 (0.14-1.15)
trend 3 0.03 0.2
AG+AA 111 (17.1) 132 (13.7) 0.77 (0.58-1.01)
VEGFA 6507bp 3' of STP G>A rs6905288
AA 357 (55.3) 499 (51.8) 1.0
AG 249 (38.5) 386 (40.0) 1.14 (0.92-1.41)
GG 40 (6.2) 81 (8.4) 1.5 (1.00-2.25)
trend 3 0.04 0.2
AG+GG 289 (44.7) 467 (48.4) 1.19 (0.97-1.46)
Gallbladder cancer
IL8 -13985C>G rs10805066
CC 647 (81.1) 187 (73.0) 1.0
CG 140 (17.5) 68 (26.6) 1.67 (1.20-2.34)
GG 11 (1.4) 1 (0.4)
trend 3 0.03 0.2
CG+GG 151 (18.9) 69 (27.0) 1.57 (1.13-2.18)
Ampulla of Vater Cancer
RNASEL IVS5+170G>A rs672527
GG 712 (83.6) 39 (73.6) 1.0
AG 133 (15.6) 11 (20.8) 1.54 (0.77-3.10)
AA 7 (0.8) 3 (5.7) 8.40 (2.06-34.14)
trend 3 0.01 0.09
AG+AA 140 (16.4) 14 (26.4) 1.88 (0.99-3.57)
IL8 -13985C>G rs10805066
CC 685 (80.4) 37 (69.8) 1.0
CG 156 (18.3) 13 (24.5) 1.59 (0.82-3.07)
GG 11 (1.3) 3 (5.7) 5.6 (1.47-21.42)
trend 3 0.02 0.1
CG+GG 167 (19.6) 16 (30.2) 1.83 (0.99-3.39)
1 Gallbladder cancer cases compared with population controls who had a gallbladder, Ampulla of Vater cancer cases compared with all population controls and
Biliary stone cases compared with population controls who did not have biliary stones; 2 Adjusted for gender and age group; 3 Test of trend for genotype under
additive model; 4 Adjusted by using the Benjamini-Hochberg method.
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http://www.biomedcentral.com/1471-2407/12/468general, in both humans and mouse models, inflamma-
tory processes, such as edema of the gallbladder,
increased organ wall thickness, inflammatory infiltrates
(the presence of inflammatory cells), and increases in
transforming growth factor (TGF)-β production [24])
lead to chronic inflammation [25,26], which may eventu-
ally lead to carcinogenesis.Although we extended the analysis of common genetic
variants to approximately 80% coverage for VEGFA
(chr6: 43827369–43870265), 90% for RNASEL (chr1:
180805238–180826133) and 75% for IL8 (chr4:
74831698–74808648), none of the overall effects for
each of the tested genes resulted in significant associa-
tions at the 0.05 level with either biliary stones or
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http://www.biomedcentral.com/1471-2407/12/468cancer. Our findings from this analysis, together with
our findings from our previous study conducted in the
same population do not strongly support an association
between a particular gene and a particular biliary dis-
ease. It may be possible that each of the current and pre-
viously examined SNPs have independent effects on
stones or biliary tract susceptibility, which is supported
by the absence of LD (D’ or r2) between the SNPs. In
addition, these variants may influence expression of dif-
ferent genes, which it is supported by the findings of re-
cent follow-up of genome-wide association studies and
the rare candidate genes [27,28]; however, we did not
find evidence of regulatory consequences for the asso-
ciated variants.
Strengths of this study include the population-based de-
sign, the high case ascertainment and response rates, and
the detailed review of pathology and clinical data to con-
firm the diagnosis of cancer cases. The use of ultrasound
among controls also minimized misclassification of gall-
stones. Although, this study is the largest population-
based study of biliary tract cancer to date, we have limited
statistical power to detect a modest association, in par-
ticular for cancer of the ampulla of Vater.
Conclusion
In conclusion, after evaluating a new set of SNPs in a
priori selected inflammatory genes, our results provide
additional data to support that genetic susceptibility
related to inflammatory mechanisms play a role in bil-
iary tract cancer and stones. Further validation of these
findings in other populations with full coverage of the
genetic variability of each of the genes would help clarify
the role of these genes in biliary tract carcinogenesis.
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